Literature DB >> 11182497

Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.

A J de Smit1, A Bouma, E P de Kluijver, C Terpstra, R J Moormann.   

Abstract

The period during which pigs are protected after vaccination is important for the successful usage of a marker vaccine against classical swine fever virus (CSFV) in an eradication programme. In four animal experiments with different vaccination-challenge intervals we determined the duration of protection of an E2 subunit marker vaccine in pigs after a single vaccination. Unvaccinated pigs were included in each group to detect transmission of the challenge virus. Three groups of six pigs were vaccinated once and subsequently inoculated with the virulent CSFV strain Brescia after a vaccination-challenge interval of 3, 51/2, 6 or 13 months. All vaccinated pigs, 16 out of 18, with neutralising antibodies against CSFV at the moment of challenge, 3, 51/2, 6 or 13 months later, survived, whereas unvaccinated control pigs died from acute CSF or were killed being moribund. A proportion of the vaccinated pigs did however develop fever or cytopenia after challenge and two vaccinated pigs were viremic after challenge. Virus transmission of vaccinated and challenged pigs to unvaccinated sentinel pigs did not occur in groups of pigs which were challenged 3 or 6 months after a single vaccination. Two out of eight vaccinated pigs that were found negative for CSFV neutralising antibody at 13 months after vaccination died after subsequent challenge. The findings in this study demonstrate that pigs can be protected against a lethal challenge of CSFV for up to 13 months after a single vaccination with an E2 subunit marker vaccine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182497     DOI: 10.1016/s0378-1135(00)00306-0

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  12 in total

1.  Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats.

Authors:  O Sánchez; M Barrera; O Farnós; N C Parra; E R Salgado; P A Saavedra; C D Meza; C I Rivas; M Cortez-San Martín; J R Toledo
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

2.  Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China.

Authors:  Ning Chen; Chao Tong; Dejiang Li; Jing Wan; Xuemei Yuan; Xiaoliang Li; Jinrong Peng; Weihuan Fang
Journal:  Virol J       Date:  2010-12-31       Impact factor: 4.099

3.  Toward the development of a one-dose classical swine fever subunit vaccine: antigen titration, immunity onset, and duration of immunity.

Authors:  Rachel F Madera; Lihua Wang; Wenjie Gong; Yulia Burakova; Sterling Buist; Jerome Nietfeld; Jamie Henningson; Ada G Cino-Ozuna; Changchun Tu; Jishu Shi
Journal:  J Vet Sci       Date:  2018-05-31       Impact factor: 1.672

4.  Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs.

Authors:  Miriam Pedrera; Francesca Macchi; Rebecca K McLean; Valentina Franceschi; Nazia Thakur; Luca Russo; Lobna Medfai; Shawn Todd; Elma Z Tchilian; Jean-Christophe Audonnet; Keith Chappell; Ariel Isaacs; Daniel Watterson; Paul R Young; Glenn A Marsh; Dalan Bailey; Simon P Graham; Gaetano Donofrio
Journal:  Vaccines (Basel)       Date:  2020-03-02

5.  Generation and efficacy evaluation of recombinant classical swine fever virus E2 glycoprotein expressed in stable transgenic mammalian cell line.

Authors:  Rong-Hong Hua; Hong Huo; Ye-Nan Li; Yao Xue; Xiao-Lei Wang; Li-Ping Guo; Bin Zhou; Yong Song; Zhi-Gao Bu
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

6.  Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge.

Authors:  Rachel Madera; Wenjie Gong; Lihua Wang; Yulia Burakova; Karen Lleellish; Amy Galliher-Beckley; Jerome Nietfeld; Jamie Henningson; Kaimin Jia; Ping Li; Jianfa Bai; John Schlup; Scott McVey; Changchun Tu; Jishu Shi
Journal:  BMC Vet Res       Date:  2016-09-09       Impact factor: 2.741

Review 7.  Classical Swine Fever-An Updated Review.

Authors:  Sandra Blome; Christoph Staubach; Julia Henke; Jolene Carlson; Martin Beer
Journal:  Viruses       Date:  2017-04-21       Impact factor: 5.048

8.  Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses.

Authors:  Francesca Macchi; José Manuel Rojas; Andrea Elizabeth Verna; Noemí Sevilla; Valentina Franceschi; Giulia Tebaldi; Sandro Cavirani; Verónica Martín; Gaetano Donofrio
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

9.  The potential efficacy of the E2-subunit vaccine to protect pigs against different genotypes of classical swine fever virus circulating in Vietnam.

Authors:  Ha Thi Thanh Tran; Duc Anh Truong; Viet Duc Ly; Hao Thi Vu; Tuan Van Hoang; Chinh Thi Nguyen; Nhu Thi Chu; Vinh The Nguyen; Duyen Thuy Nguyen; Kohtaro Miyazawa; Takehiro Kokuho; Hoang Vu Dang
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31

10.  Identification of E2 with improved secretion and immunogenicity against CSFV in piglets.

Authors:  Huiling Xu; Yanli Wang; Guangwei Han; Weihuan Fang; Fang He
Journal:  BMC Microbiol       Date:  2020-02-04       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.